{"id":745347,"date":"2016-07-01T11:05:00","date_gmt":"2016-07-01T11:05:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/"},"modified":"2025-11-07T01:25:43","modified_gmt":"2025-11-07T06:25:43","slug":"merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/","title":{"rendered":"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A."},"content":{"rendered":"<p class=\"bwalignc\">        Manufacturer Offers Substantial Portfolio of Animal Vaccines in        Latin America      <\/p>\n<p>\n      Merck Animal Health (known as MSD Animal Health outside the United<br \/>\n      States and Canada) today announced it has executed an agreement to<br \/>\n      acquire a controlling interest in Vall\u00e9e S.A., a leading privately-held<br \/>\n      producer of animal health products in Brazil.\n    <\/p>\n<p>\n      Vall\u00e9e has an extensive portfolio of more than 100 products spanning<br \/>\n      parasiticides, anti-infectives and vaccines. The company\u2019s portfolio<br \/>\n      includes products for livestock, horses, and companion animals. Vall\u00e9e<br \/>\n      was founded with the mission of producing a Foot and Mouth Disease (FMD)<br \/>\n      vaccine for Brazil and has expanded significantly, with distribution<br \/>\n      centers in Brazil and operations in Paraguay, Venezuela, Mexico and<br \/>\n      Bolivia.\n    <\/p>\n<p>\n      \u201cMerck Animal Health has a broad portfolio of products to protect<br \/>\n      against some of the most important pathogens affecting livestock,\u201d said<br \/>\n      Rick DeLuca, president, Merck Animal Health. \u201cWe are pleased to<br \/>\n      complement our portfolio with products from Vall\u00e9e, which will further<br \/>\n      strengthen our presence in Latin America and help us respond even more<br \/>\n      quickly and effectively to the region\u2019s needs.\u201d\n    <\/p>\n<p>\n      The agriculture industry is an important driver of the economy in Latin<br \/>\n      America. This region contributes 11% of the value of the world food<br \/>\n      production<sup>1<\/sup> and a significant number of the cattle in the<br \/>\n      region are vaccinated with Vall\u00e9e S.A. vaccines.\n    <\/p>\n<p>\n      \u201cAs one of the largest producers of protein in the world, Brazil is an<br \/>\n      important market for us,\u201d explains Ralph Cabezas, vice president, Latin<br \/>\n      America region, Merck Animal Health. \u201cVall\u00e9e has been a trusted<br \/>\n      manufacturing partner in this region for a number of years and we are<br \/>\n      pleased to offer their products to our customers to help protect animals<br \/>\n      from diseases.\u201d\n    <\/p>\n<p>\n      Under terms of the agreement, Merck Animal Health, through a subsidiary,<br \/>\n      will acquire approximately 93% of the shares of Vall\u00e9e S.A. at closing,<br \/>\n      in exchange for a payment of $400 million, based on current exchange<br \/>\n      rates. This agreement is subject to regulatory review and certain<br \/>\n      closing conditions.\n    <\/p>\n<p>\n      <b>About Merck Animal Health<\/b>\n    <\/p>\n<p>\n      For 125 years, Merck has been a global health care leader working to<br \/>\n      help the world be well. Merck Animal Health, known as MSD Animal Health<br \/>\n      outside the United States and Canada, is the global animal health<br \/>\n      business unit of Merck (NYSE:MRK). Through its commitment to the Science<br \/>\n      of Healthier Animals\u2122, Merck Animal Health offers veterinarians,<br \/>\n      farmers, pet owners and governments one of the widest range of<br \/>\n      veterinary pharmaceuticals, vaccines and health management solutions and<br \/>\n      services. Merck Animal Health is dedicated to preserving and improving<br \/>\n      the health, well-being and performance of animals. It invests<br \/>\n      extensively in dynamic and comprehensive R&amp;D resources and a modern,<br \/>\n      global supply chain. Merck Animal Health is present in more than 50<br \/>\n      countries, while its products are available in some 150 markets. For<br \/>\n      more information, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck-animal-health.com&amp;esheet=51373372&amp;newsitemid=20160701005700&amp;lan=en-US&amp;anchor=www.merck-animal-health.com&amp;index=1&amp;md5=3c5a2a90435e86de7ec8ce42d5682944\" rel=\"nofollow\">www.merck-animal-health.com<\/a>&nbsp;or<br \/>\n      connect with us on <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck-animal-health%3Ftrk%3Dcompany_name&amp;esheet=51373372&amp;newsitemid=20160701005700&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=840e27fea66c0c41763048df2336bee1\" rel=\"nofollow\">LinkedIn<\/a>,<br \/>\n      <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fmerckanimalhealth%2F%3Ffref%3Dts&amp;esheet=51373372&amp;newsitemid=20160701005700&amp;lan=en-US&amp;anchor=Facebook&amp;index=3&amp;md5=6661a3addad56ef6977c5343de36502e\" rel=\"nofollow\">Facebook<\/a><br \/>\n      and Twitter at @MerckAH.\n    <\/p>\n<p>\n      <b>Forward-Looking Statement of Merck &amp; Co., Inc., Kenilworth, N.J., USA<\/b>\n    <\/p>\n<p>\n      This news release of Merck &amp; Co., Inc., Kenilworth, N.J., USA (the<br \/>\n      \u201ccompany\u201d) includes \u201cforward-looking statements\u201d within the meaning of<br \/>\n      the safe harbor provisions of the U.S. Private Securities Litigation<br \/>\n      Reform Act of 1995. These statements are based upon the current beliefs<br \/>\n      and expectations of the company\u2019s management and are subject to<br \/>\n      significant risks and uncertainties. If underlying assumptions prove<br \/>\n      inaccurate or risks or uncertainties materialize, actual results may<br \/>\n      differ materially from those set forth in the forward-looking statements.\n    <\/p>\n<p>\n      Risks and uncertainties include but are not limited to, general industry<br \/>\n      conditions and competition; general economic factors, including interest<br \/>\n      rate and currency exchange rate fluctuations; the impact of<br \/>\n      pharmaceutical industry regulation and health care legislation in the<br \/>\n      United States and internationally; global trends toward health care cost<br \/>\n      containment; technological advances, new products and patents attained<br \/>\n      by competitors; challenges inherent in new product development,<br \/>\n      including obtaining regulatory approval; the company\u2019s ability to<br \/>\n      accurately predict future market conditions; manufacturing difficulties<br \/>\n      or delays; financial instability of international economies and<br \/>\n      sovereign risk; dependence on the effectiveness of the company\u2019s patents<br \/>\n      and other protections for innovative products; and the exposure to<br \/>\n      litigation, including patent litigation, and\/or regulatory actions.\n    <\/p>\n<p>\n      The company undertakes no obligation to publicly update any<br \/>\n      forward-looking statement, whether as a result of new information,<br \/>\n      future events or otherwise. Additional factors that could cause results<br \/>\n      to differ materially from those described in the forward-looking<br \/>\n      statements can be found in the company\u2019s 2015 Annual Report on Form 10-K<br \/>\n      and the company\u2019s other filings with the Securities and Exchange<br \/>\n      Commission (SEC) available at the SEC\u2019s Internet site (<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=51373372&amp;newsitemid=20160701005700&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=4&amp;md5=a5e14298afa3428dd951ff3016be2a18\" rel=\"nofollow\">www.sec.gov<\/a>).\n    <\/p>\n<p>\n      <sup>1<\/sup> Inter-American Development Bank website <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iadb.org%2Fen%2Ftopics%2Fagriculture%2Flatin-american-agriculture-statistics%2C2342.html&amp;esheet=51373372&amp;newsitemid=20160701005700&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.iadb.org%2Fen%2Ftopics%2Fagriculture%2Flatin-american-agriculture-statistics%2C2342.html&amp;index=5&amp;md5=90017e31459588d3202fdd0677dc9e7f\" rel=\"nofollow\">http:\/\/www.iadb.org\/en\/topics\/agriculture\/latin-american-agriculture-statistics,2342.html<\/a>.<br \/>\n      Accessed on May 24, 2016.\n    <\/p>\n<p>\n<img decoding=\"async\" alt=\"\" src=\"\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20160701005700r1&amp;sid=hq1sc1&amp;distro=nx&amp;lang=en\"><br \/>\n<span class=\"bwct31415\"><br \/>\n<\/span><\/p>\n<p>       Merck Animal Health <br \/>Media:<br \/>Amy Firsching,        +1-973-937-5453<br \/> <a href=\"mailto:amy.firsching@merck.com\">amy.firsching@merck.com<\/a> <br \/>or<br \/>Pam        Eisele, + 1-267-305-3558<br \/> <a href=\"mailto:pamela.eisele@merck.com\">pamela.eisele@merck.com<\/a> <br \/>or<br \/>Investors:<br \/>Amy        Klug, +1-908-740-1898<br \/> <a href=\"mailto:Amy.klug@merck.com\">Amy.klug@merck.com<\/a>     <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Manufacturer Offers Substantial Portfolio of Animal Vaccines in Latin America Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced it has executed an agreement to acquire a controlling interest in Vall\u00e9e S.A., a leading privately-held producer of animal health products in Brazil. Vall\u00e9e has an extensive portfolio of more than 100 products spanning parasiticides, anti-infectives and vaccines. The company\u2019s portfolio includes products for livestock, horses, and companion animals. Vall\u00e9e was founded with the mission of producing a Foot and Mouth Disease (FMD) vaccine for Brazil and has expanded significantly, with distribution centers in Brazil and operations in Paraguay, Venezuela, Mexico and Bolivia. \u201cMerck Animal Health has a broad portfolio of products to protect against some of the most important pathogens affecting livestock,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cWe are pleased to complement our portfolio with products<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[65,53,64,289],"class_list":["post-745347","news_item","type-news_item","status-publish","hentry","tag-animal-health","tag-corporate-news","tag-latest-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A. - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A. - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Manufacturer Offers Substantial Portfolio of Animal Vaccines in Latin America Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced it has executed an agreement to acquire a controlling interest in Vall\u00e9e S.A., a leading privately-held producer of animal health products in Brazil. Vall\u00e9e has an extensive portfolio of more than 100 products spanning parasiticides, anti-infectives and vaccines. The company\u2019s portfolio includes products for livestock, horses, and companion animals. Vall\u00e9e was founded with the mission of producing a Foot and Mouth Disease (FMD) vaccine for Brazil and has expanded significantly, with distribution centers in Brazil and operations in Paraguay, Venezuela, Mexico and Bolivia. \u201cMerck Animal Health has a broad portfolio of products to protect against some of the most important pathogens affecting livestock,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cWe are pleased to complement our portfolio with products\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T06:25:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3056\" \/>\n\t<meta property=\"og:image:height\" content=\"1380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\\\/\",\"name\":\"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A. - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"datePublished\":\"2016-07-01T11:05:00+00:00\",\"dateModified\":\"2025-11-07T06:25:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A. - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/","og_locale":"en_US","og_type":"article","og_title":"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A. - Merck.com","og_description":"Manufacturer Offers Substantial Portfolio of Animal Vaccines in Latin America Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced it has executed an agreement to acquire a controlling interest in Vall\u00e9e S.A., a leading privately-held producer of animal health products in Brazil. Vall\u00e9e has an extensive portfolio of more than 100 products spanning parasiticides, anti-infectives and vaccines. The company\u2019s portfolio includes products for livestock, horses, and companion animals. Vall\u00e9e was founded with the mission of producing a Foot and Mouth Disease (FMD) vaccine for Brazil and has expanded significantly, with distribution centers in Brazil and operations in Paraguay, Venezuela, Mexico and Bolivia. \u201cMerck Animal Health has a broad portfolio of products to protect against some of the most important pathogens affecting livestock,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cWe are pleased to complement our portfolio with products","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/","og_site_name":"Merck.com","article_modified_time":"2025-11-07T06:25:43+00:00","og_image":[{"width":3056,"height":1380,"url":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/","name":"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A. - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"datePublished":"2016-07-01T11:05:00+00:00","dateModified":"2025-11-07T06:25:43+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vall\u00e9e S.A."}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"c4b58435-d596-40b3-8ac7-92e9b3968462","news_item_aria_label":"","media_files":null,"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Merck-Animal-Health-Announces-Agreement-to-Acquire-Controlling-Interest-In-Brazilian-Animal-Health-Company-Valle-SA-2016.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745347\/revisions"}],"predecessor-version":[{"id":3674752,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/745347\/revisions\/3674752"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=745347"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=745347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}